Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Rob Elston, PhD
Clinical Development (Infectious Disease) GSK
GSK, Stevenage, Hertfordshire, UK, United Kingdom
Poster(s):
049: Assessment of the Effect of HBV Viral Genotype on Bepirovirsen Efficacy Using a Population Pharmacokinetic/Pharmacodynamic Modeling Approach
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET